Defective DNA Damage Response Is a Targetable Therapeutic Vulnerability in ESR1-Mutant Breast Cancer

Journal:

Cancer Research

Published:

2026-04-01

DOI:

10.1158/0008-5472.can-24-3891

Affiliations:

9

Authors:

19

Go to article

Institutions	Authors	Share
Baylor College of Medicine (BCM), United States of America (USA)	13.666667 13.666667	0.72
University of Houston (UH), United States of America (USA)	2.000000	0.11
Dan L. Duncan Comprehensive Cancer Center, United States of America (USA)	1.333333	0.07
Cleveland Clinic, United States of America (USA)	1.000000	0.05
The University of Texas MD Anderson Cancer Center, United States of America (USA)	1.000000	0.05

Interested in Oncology and Carcinogenesis?